Citations

Clear

2960 citation(s) found for "Kim, P".

Anastrozole Increases Predicted Adult Height of Short Adolescent Males Treated with Growth Hormone: A Randomized, Placebo-Controlled, Multicenter Trial for One to Three Years
Mauras, Nelly , Pijem, Lilliam Gonzalez de, Hsiang, Helen Y., Desrosiers, Paul, Rapaport, Robert , Schwartz, I. David, Klein, Karen O. , Miyamoto, Anna, Bishop, Kim, Singh, Ravinder J.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | December 28, 2007 | Volume: 93 | Issue: 3 | Pages: 823-831

10.1210/jc.2007-1559 | PMID 18165285 Get It

Abstract Context: The process of epiphyseal fusion during puberty is regulated by estrogen, even in males. Objective: Our objective was to investigate whether anastrozole, a potent aromatase inhibitor, could delay bone age acceleration and increase predicted adult height in adolescent boys with GH deficiency. Methods: Fifty-two adolescent males with GH deficiency treated with GH were randomized to cotreatment with anastrozole or placebo daily for up to 36 months. Results: Fifty subjects completed 12 months, 41 completed 24 months, and 28 completed 36 months. Linear growth was comparable between groups; however, there was a significantly slower increase in bone age advancement from baseline in the anastrozole group vs. placebo group after 2 yr (+1.8 ± 0.1 vs. +2.7 ± 0.1 yr, P < 0.0001) and after 3 yr (+2.5 ± 0.2 vs. +4.1 ± 0.1 yr, P < 0.0001). This resulted in a net increase in predicted adult height of +4.5 ± 1.2 cm in the anastrozole group at 24 months and +6.7 ± 1.4 cm at 36 months as compared with a 1-cm gain at both time points in the placebo group. Estradiol and estrone concentrations increased less in the anastrozole group compared with placebo group. All boys on the aromatase inhibitor had normal tempo of virilization. Safety data, including glucose, and plasma lipid concentrations were comparable between groups. Conclusions: Anastrozole increases adult height potential of adolescent boys on GH therapy while maintaining normal pubertal progression after 2–3 yr. This treatment offers an alternative in promoting growth in GH-deficient boys in puberty. Long-term follow up is needed to elucidate fully the safety and efficacy of this approach.
MUC1 Mucin Is a Negative Regulator of Toll-Like Receptor Signaling
Ueno, Keiko , Koga, Takeshi , Kato, Kosuke , Golenbock, Douglas T. , Gendler, Sandra , Kai, Hirofumi , Kim, K. Chul

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | December 13, 2007 | Volume: 38 | Issue: 3 | Pages: 263-268

10.1165/rcmb.2007-0336rc | PMID 18079492 Get It

Abstract MUC1 (MUC1 in humans and Muc1 in nonhuman species) is a transmembrane mucin-like glycoprotein expressed in epithelial cells lining various mucosal surfaces as well as hematopoietic cells. Recently, we showed that Muc1−/− mice exhibited greater inflammatory responses to Pseudomonas aeruginosa or its flagellin compared with their wild-type littermates, and our studies with cultured cells revealed that MUC1/Muc1 suppressed the Toll-like receptor (TLR) 5 signaling pathway, suggesting its anti-inflammatory role. Here we demonstrate that other TLR signaling (TLR2, 3, 4, 7, and 9) is also suppressed by MUC1/Muc1. The results from this study suggest that MUC1/Muc1 may play a crucial role during airway infection and inflammation by various pathogenic bacteria and viruses.
Synthesis and Evaluation of Novel Biodegradable Hydrogels Based on Poly(ethylene glycol) and Sebacic Acid as Tissue Engineering Scaffolds
Kim, Jinku , Lee, Kee‐Won , Hefferan, Theresa E., Currier, Bradford L. , Yaszemski, Michael J. , Lu, Lichun

Mayo Clinic

Biomacromolecules | December 12, 2007 | Volume: 9 | Issue: 1 | Pages: 149-157

10.1021/bm700924n | PMID 18072747 Get It

Predictive Value of Microsatellite Instability-High Remains Controversial
Kim, George P., Colangelo, Linda H., Paik, Soonmyung , Allegra, Carmen J. , O’Connell, Michael J. , Kirsch, Ilan R. , Wolmark, Norman

Mayo Clinic

Journal of Clinical Oncology | October 18, 2007 | Volume: 25 | Issue: 30 | Pages: 4857-4857

10.1200/jco.2007.13.2019 | PMID 17947740 Get It

Pathogenesis of Graves' Ophthalmopathy: The Role of Autoantibodies
Khoo, Teck Kim, Bahn, Rebecca S.

Mayo Clinic

Thyroid | October 12, 2007 | Volume: 17 | Issue: 10 | Pages: 1013-1018

10.1089/thy.2007.0185 | PMID 17935483 Get It

Amyloid-β(1−42) Rapidly Forms Protofibrils and Oligomers by Distinct Pathways in Low Concentrations of Sodium Dodecylsulfate
Rangachari, Vijayaraghavan , Moore, Brenda D. , Reed, Dana Kim , Sonoda, Leilani K., Bridges, Alexander W., Conboy, Erin , Hartigan, David E. , Rosenberry, Terrone L.

Mayo Clinic

Biochemistry | October 2, 2007 | Volume: 46 | Issue: 43 | Pages: 12451-12462

10.1021/bi701213s | PMID 17910477 Get It

Predisposition to Vasovagal Syncope in Subjects With Blood/Injury Phobia
Accurso, Valentina, Winnicki, Mikołaj, Shamsuzzaman, Abu, Wenzel, Amy, Johnson, Alan Kim , Somers, Virend K.

Mayo Clinic

Circulation | September 28, 2007 | Volume: 104 | Issue: 8 | Pages: 903-907

10.1161/hc3301.094910 | PMID 11514377 Get It

Background — Most subjects with blood/injury phobia experience syncope or presyncope as part of the phobic response. We tested the hypothesis that these subjects have a constitutional autonomic dysregulation that predisposes them to vasovagal syncope during head-up tilt. Methods and Results — We studied 11 subjects (9 females, 2 males) who had a history of syncope or presyncope only in response to a blood or injury stimulus and 11 healthy matched controls (10 females, 1 male) without a history of syncope. Blood pressure (BP) and heart rate (HR) were measured during a 15-minute baseline period with subjects in the supine position and then during 45 minutes of head-up tilt to 70°. Measurements at rest did not differ between the blood phobic and control subjects. During tilt, 9 (82%) of the 11 blood phobic subjects experienced presyncope or syncope, leading to termination of the study after 22±17 minutes of tilt. Only 1 (9%) of the 11 control subjects experienced presyncope (χ 2 =11.7, P =0.001). Hemodynamic responses to tilt were consistent with a vasovagal mechanism in the blood phobic subjects, with simultaneous decreases in BP and HR during tilt. During tilt, systolic BP fell by 21±15 mm Hg ( P =0.001), and HR fell by 22±25 bpm ( P =0.01). By contrast, BP and HR were very stable in the control group. Conclusions — Subjects with syncope related to blood/injury phobia have an underlying autonomic dysregulation predisposing them to neurally mediated syncope, even in the absence of any blood or injury stimulus. Fainting related to these stimuli may in large part be due to dysfunction in neural circulatory control, which may secondarily lead to the phobia because of repeated syncopal events.
Aortic Diameter ≥5.5 cm Is Not a Good Predictor of Type A Aortic Dissection
Pape, Linda, Tsai, Thomas T., Oh, Jae K. , Evangelista, Arturo , Fattori, Rossella , Meinhardt, Gabriel, Trimarchi, Santi , Bossone, Eduardo , Cooper, Jeanna V., Froehlich, James B. , Isselbacher, Eric M. , O’Gara, Patrick T. , Suzuki, Toru , Nienaber, Christoph , Eagle, Kim A. , Bossone, Eduardo

Mayo Clinic

Circulation | August 21, 2007 | Volume: 116 | Issue: 10 | Pages: 1120-1127

10.1161/circulationaha.107.702720 | PMID 17709637 Get It

Background— Studies of aortic aneurysm patients have shown that the risk of rupture increases with aortic size. However, few studies of acute aortic dissection patients and aortic size exist. We used data from our registry of acute aortic dissection patients to better understand the relationship between aortic diameter and type A dissection. Methods and Results— We examined 591 type A dissection patients enrolled in the International Registry of Acute Aortic Dissection between 1996 and 2005 (mean age, 60.8 years). Maximum aortic diameters averaged 5.3 cm; 349 (59%) patients had aortic diameters <5.5 cm and 229 (40%) patients had aortic diameters <5.0 cm. Independent predictors of dissection at smaller diameters (<5.5 cm) included a history of hypertension (odds ratio, 2.17; 95% confidence interval, 1.03 to 4.57; P =0.04), radiating pain (odds ratio, 2.08; 95% confidence interval, 1.08 to 4.0; P =0.03), and increasing age (odds ratio, 1.03; 95% confidence interval, 1.00 to 1.05; P =0.03). Marfan syndrome patients were more likely to dissect at larger diameters (odds ratio, 14.3; 95% confidence interval, 2.7 to 100; P =0.002). Mortality (27% of patients) was not related to aortic size. Conclusions— The majority of patients with acute type A acute aortic dissection present with aortic diameters <5.5 cm and thus do not fall within current guidelines for elective aneurysm surgery. Methods other than size measurement of the ascending aorta are needed to identify patients at risk for dissection.
Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Collard, Harold R. , Moore, Bethany B. , Flaherty, Kevin R. , Brown, Kevin M. , King, Talmadge E. , Lasky, Joseph A. , Loyd, James E. , Noth, Imre , Olman, Mitchell A. , Raghu, Ganesh , Roman, Jesse , Ryu, Jay H. , Zisman, David A., Hunninghake, Gary W., Colby, Thomas V. , Egan, Jim, Hansell, David M., Johkoh, Takeshi , Kaminski, Naftali , Kim, Dong Soon, Lynch, David A. , Müller–Quernheim, Joachim, Selman, Moisés , Toews, Galen B., Wells, Athol U. , Kaner, Robert J. , Kondoh, Yasuhiro , Myers, Jeffrey L. , Nicholson, Andrew G. , Martínez, Fernando J. , Kaminski, Naftali , Ryu, Jay H , Loyd, James E

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | June 21, 2007 | Volume: 176 | Issue: 7 | Pages: 636-643

10.1164/rccm.200703-463pp | PMID 17585107 Get It

Abstract The natural history of idiopathic pulmonary fibrosis (IPF) has been characterized as a steady, predictable decline in lung function over time. Recent evidence suggests that some patients may experience a more precipitous course, with periods of relative stability followed by acute deteriorations in respiratory status. Many of these acute deteriorations are of unknown etiology and have been termed acute exacerbations of IPF. This perspective is the result of an international effort to summarize the current state of knowledge regarding acute exacerbations of IPF. Acute exacerbations of IPF are defined as acute, clinically significant deteriorations of unidentifiable cause in patients with underlying IPF. Proposed diagnostic criteria include subjective worsening over 30 days or less, new bilateral radiographic opacities, and the absence of infection or another identifiable etiology. The potential pathobiological roles of infection, disordered cell biology, coagulation, and genetics are discussed, and future research directions are proposed.
Hip Arthroscopy: An Emerging Gold Standard
Beaulé, Paul E. , Clohisy, John C. , Schoenecker, Perry L. , Kim, Young‐Jo , Millis, Michael B. , Trousdale, Robert T. , Beaulé, Paul E

Mayo Clinic

Arthroscopy | June 8, 2007 | Volume: 23 | Issue: 6 | Pages: 682-682

10.1016/j.arthro.2007.03.007 | PMID 17560490 Get It